Concepedia

Greg Henkel

GH

12

Publications

648

Citations

11

H-Index

1992

Active since

Affiliations

Arisan Therapeutics (United States)(Current)

Oregon Health & Science University

Vertex Pharmaceuticals (United States)

University of California San Diego

Novartis (United States)

Greg Henkel is an author at Arisan Therapeutics (United States) specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1992–2022

12

Publications

12

IL-Converting Enzyme/Caspase-1 Inhibitor VX-765 Blocks the Hypersensitive Response to an Inflammatory Stimulus in Monocytes from Familial Cold Autoinflammatory Syndrome Patients

Jeffrey H. Stack, Kevin Beaumont, Paul D. Larsen et al. · The Journal of Immunology · 2005 · 187 citations · Full text

PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer.

Greg Henkel, Matthew A. Brown · Proceedings of the National Academy of Sciences · 1994 · 122 citations · Full text

, , +19

An Intron Transcriptional Enhancer Element Regulates IL-4 Gene Locus Accessibility in Mast Cells

John Hural, Millie Kwan, Greg Henkel et al. · The Journal of Immunology · 2000 · 79 citations · Full text

A DNase I-hypersensitive site in the second intron of the murine IL-4 gene defines a mast cell-specific enhancer

Greg Henkel, D L Weiss, R. J. McCoy et al. · The Journal of Immunology · 1992 · 78 citations

Nuclear Factor of Activated T Cells Is Associated with a Mast Cell Interleukin 4 Transcription Complex

D L Weiss, John Hural, David Tara et al. · Molecular and Cellular Biology · 1996 · 76 citations · Full text

, , +20

Rows per page

1–5 of 12